Prophylactic intravenous immune globulin and polymixin B decrease the incidence of septic episodes and hospital length of stay in severely burned children

Journal of Burn Care and Research

Volumn 27, Issue 6, 2006, Pages 813-818

  Lyons, Jefferson M ^a   Davis, Christopher ^a   Rieman, Mary T ^b   Kopcha, Robert ^b   Phan, Ho ^c   Greenhalgh, David ^c   Palmieri, Tina ^c   Kagan, Richard ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

^c SHRINERS HOSPITALS FOR CHILDREN NORTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; POLYMYXIN B;

BURN; BURN PATIENT; CHILD; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; LENGTH OF STAY; LUNG BURN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PROPHYLAXIS; REVIEW; SEPSIS; STATISTICAL SIGNIFICANCE; THERMAL INJURY; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BURNS; CHILD; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; LENGTH OF STAY; MALE; POLYMYXIN B; RETROSPECTIVE MORAL JUDGMENT; SHOCK, SEPTIC; SMOKE INHALATION INJURY; TRAUMA SEVERITY INDICES;

EID: 33750836641     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/01.BCR.0000245421.54312.36     Document Type: Review

References (17)

1. Munster AM, Hoagland HC, Pruitt BA. The effect of thermal injury on serum immunoglobulins. Ann Surg 1970;172:965-9.
2. Munster AM. New horizons in surgical immunobiology. Ann Roy Coll Surg Engl 1972;51:69-80.
3. Grob P, Holch M, Fierez W, Glinz W, Geroulanos S. Immunodeficiency after major trauma and selective surgery. Pediatr Infect Dis J. 1988;7 (Suppl 5):S37-42.
4. Munster AM, Xiao GX, Guo Y, Wong LA, Winchurch RA. Control of endotoxemia in burn patients by use of polymixin B. J Burn Care Rehabil 1989;10:327-30.
5. Chiccone TG, Munster AM, Birmingham W, Winchurch RA. Successful immunomodulation in burned animals and human beings with homeopathic doses of polymixin B. J Burn Care Rehabil 1983;4:153-7.
6. Shirani KZ, Vaughan GM, McManus AT, et al. Replacement therapy with modified immunoglobulin g in burn patients: preliminary kinetic studies. Am J Med 1984;76:175-80.
7. Waymack JP, Jenkins ME, Alexander JW, et al. A prospective randomized trial of prophylactic intravenous immune globulin for the prevention of infections in severely burned patients. Burns 1989;15:71-6.
8. Brown DL, Archer SB, Greenhalgh DG, et al. Inhalation injury severity scoring system: a quantitative method. J Burn Care Rehabil 1996;17:552-7.
9. Neely AN, Smith WL, Warden GD. Efficacy of a rise in C-reactive protein serum levels as an early indicator of sepsis in burned children. J Burn Care Rehabil 1998;19:102-5.
10. Sevitt S. A review of the complications of burns, their origin and importance for illness and death. J Trauma 1979;19:358.
11. Jacobs DM, Morrison DC. Inhibition of mitogenic response to lipopolysaccharide (LPS) in mouse spleen cell by polymixin-B. B J Immunology 1977;118:21-7.
12. Munster AM, Moran KT, Thupari J, Allo M, Winchurch RA. Prophylactic intravenous immunoglobulin replacement in high risk burn patients. J Burn Care Rehabil 1987;8:376-80.
13. Dibirdik I, Durak N, Kislaoglu E, Kutluay T, Aytemiz C. Effects of prophylactic immunoglobulin-G therapy on humoral and cellular immune components and their functions in burned patients. Burns 1995;21:130-5.
14. Glinz W, Grob PJ, Nydegger UE, et al. Polyvalent immunoglobulins for prophylaxis of bacterial infections in patients with multiple trauma. Intensive Care Med 1985;11:288-94.
15. Cometta A, Baumgartner JD, Lee M, Glauser MP, the Anti-Core LPSIVIG Collaborative Study Group. Prophylactic intravenous administration of standard immune globulin as compared with core-lipopolysaccharide immune globulin in patients at high risk of post-surgical infection. N Engl J Med 1992;327:234-40.
16. Duswald KH, Muller K, Seifert J, Rinz J. Wirksamkeit von i.v. Gammaglobulin gegen bakterielle Infektionen chirurgischer patienten. Munch Med Wschr 1980;122:832-6.
17. Shortt R, Gomez M, Mittman N, Cartotto R. Intravenous immunoglobulin does not improve outcome in toxic epidermal necrolysis. J Burn Care Rehabil 2004;25:246-55.